JP Morgan Maintains Overweight on Hologic, Raises Price Target to $95
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Casey Woodring maintains an Overweight rating on Hologic (NASDAQ:HOLX) and raises the price target from $91 to $95.
July 30, 2024 | 12:57 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
JP Morgan analyst Casey Woodring maintains an Overweight rating on Hologic and raises the price target from $91 to $95.
The Overweight rating and increased price target from a reputable analyst at JP Morgan is likely to positively impact Hologic's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100